Original Article
Author Details :
Volume : 9, Issue : 3, Year : 2024
Article Page : 104-109
https://doi.org/10.18231/j.ijirm.2024.021
Abstract
Background and Objectives: Though there were several clinical studies available on the management of allergic rhinitis (AR), there is a lack of studies among clinicians in actual practice. So, this study was conducted to gather clinicians' opinion regarding the use of antihistamines, with a special focus on bilastine, in managing AR in Indian settings.
Materials and Methods: This cross-sectional, multiple-response questionnaire-based study involving 26 questions gathered information on feedback, clinical observations, clinical experience of specialists pertaining to AR management, and the use of antihistamines in routine settings. The data were analyzed using descriptive statistics.
Results: Majority (88.33%) of the clinicians reported that bilastine was the preferred antihistamine choice for treating patients with AR. Non-sedating action was the key factor considered when choosing an antihistamine medication for a patient with AR. Half of the clinicians (50.56%) opined that the cost of treatment when managing patients with AR was very important. According to 57% of the clinicians, the primary advantages of bilastine include its non-sedating nature, organ-friendly profile, and rapid onset of action within 24 hours. About 63% of the clinicians reported that antihistamines + montelukast was the preferred combination for managing patients with persistent AR.
Conclusion: This study indicated the clinician’s preference for using bilastine for treating AR in routine settings, due to its non-sedating nature and rapid onset of action. Antihistamines combined with montelukast were also a preferred treatment option for clinicians managing patients with persistent AR.
Keywords: Allergic rhinitis, Bilastine, Antihistamines, Nonsedative, Montelukast
How to cite : Manjula S, Krishna Kumar M, Expert perspectives on the use of antihistamines in managing allergic rhinitis in Indian settings: A cross-sectional study. IP Indian J Immunol Respir Med 2024;9(3):104-109
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Received : 17-07-2024
Accepted : 24-09-2024
Viewed: 339
PDF Downloaded: 53